​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $118.50, with a high of $135.00 and a low of $90.00. This represents a 10.85% increase from the last price of $106.90.

$90 $99 $108 $117 $126 $135 High: $135 Avg: $118.5 Low: $90 Last Closed Price: $106.9

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (69.44%), 10 Hold (27.78%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 10 25 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck10.85%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks5.12%

Price Target Trends

1M3M12M
# Anlaysts31014
Avg Price Target$127.00$119.50$112.21
Last Closing Price$106.90$106.90$106.90
Upside/Downside18.80%11.79%4.97%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2621512--29
Dec, 2521413--29
Nov, 2521313--28
Oct, 2521313--28
Sep, 2521213--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 27, 2026Cantor Fitzgerald$116.00$107.408.01%8.51%
Jan 08, 2026Wolfe Research$135.00$108.5924.32%26.29%
Jan 07, 2026UBS$130.00$110.9617.16%21.61%
Dec 18, 2025BMO Capital$130.00$99.2131.04%21.61%
Dec 12, 2025Morgan Stanley$102.00$100.061.94%-4.58%
Dec 10, 2025Rajesh KumarHSBC$120.00$96.8923.85%12.25%
Dec 05, 2025Guggenheim$122.00$100.8920.92%14.13%
Dec 04, 2025Louise ChenScotiabank$120.00$101.8817.79%12.25%
Dec 02, 2025Asad HaiderGoldman Sachs$120.00$101.8317.84%12.25%
Nov 03, 2025Terence FlynnMorgan Stanley$100.00$84.6518.13%-6.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 27, 2026Cantor FitzgeraldNeutralNeutralhold
Jan 27, 2026CitigroupNeutralNeutralhold
Jan 20, 2026Cowen & Co.HoldHoldhold
Jan 08, 2026Wolfe ResearchOutperformOutperformupgrade
Jan 07, 2026UBSBuyBuyhold
Jan 07, 2026CitigroupNeutralNeutralhold
Jan 06, 2026CitigroupBuyBuyhold
Dec 18, 2025BMO CapitalMarket PerformOutperformupgrade
Dec 10, 2025HSBCBuyBuyhold
Dec 05, 2025GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.16$5.73$0.14$6.74----
Avg Forecast$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-10.88%-22.46%-89.86%-13.14%----

Revenue Forecast

$45B $52B $59B $66B $73B $80B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.70B$59.28B$60.12B$64.17B----
Avg Forecast$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %0.38%0.27%0.24%0.28%----

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.05B$14.52B$365.00M$17.12B----
Avg Forecast$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %6.36%-2.62%--13.37%----

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 10 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 36 Wall Street analysts, averages $118.5 over the next 12 months. The price target range spans from $90 at the low end to $135 at the high end, suggesting a potential 10.85% change from the previous closing price of $106.9.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 10.85% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (5.12%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • January 2026: 6.90% Strong Buy, 51.72% Buy, 41.38% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 6.90% Strong Buy, 48.28% Buy, 44.83% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 7.14% Strong Buy, 46.43% Buy, 46.43% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2025 is $9.23, marking a 36.94% increase from the reported $6.74 in 2024. Estimates for the following years are $10.03 in 2026, $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2025 is $67.11B, reflecting a 4.58% increase from the reported $64.17B in 2024. The forecast for 2026 is $70.95B, followed by $74.43B for 2027, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2025 stands at $21.95B, representing an 28.26% increase from the reported $17.12B in 2024. Projections indicate $24.45B in 2026, $26.84B in 2027, and $27.37B in 2028.